Our Mission

Who we are

The Quebec Cancer Consortium for Novel Therapeutics and Biomarkers (QCC) is a collaborative network of four hospitals, with their respective research centres, and two university-based cancer research centres. Its goals are to standardize and harmonize practices in clinical and translational research, to improve cancer treatment by accelerating advances in precision medicine and immuno-oncology, and to engage with cancer patients to develop educational material and raise awareness of clinical trials of precision medicine and immunotherapies.

What we do

The QCC is accelerating research on molecular diagnostics and therapeutics for cancer and putting patients’ experiences and needs front and centre.

QCC members are collaborating to advance cancer research and save lives by:

  • Developing infrastructure to fuel the discovery and development of new precision cancer therapies and diagnostic tests to match patients with the best possible treatments.
  • Translating discoveries from the laboratory to the clinic.
  • Educating patients on the essential role of clinical trials in developing new treatments.
  • Empowering patients to participate in ongoing and future precision oncology and immunotherapy clinical trials.

What we stand for

We are committed to promoting:

  • Scientific Excellence through fostering innovative clinical and translational research based on principles of integrity and ethical practices.
  • Multidisciplinary Collaboration across institutions through sharing data and resources, integrating technological platforms and standardizing practices and protocols.
  • Patient engagement through partnering with communities to develop inclusive scientific priorities, clinical trials, and research projects.